免疫血液学の世界市場レポート 2025年

免疫血液学市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.9％で、32億4,000万米ドルに成長します。予測期間の成長は、ポイントオブケア検査需要の増加、新規血液製剤の出現、ヘルスケアインフラの拡大、血液適合性の遺伝子検査、血液の安全性に関する規制支援などに起因すると考えられます。予測期間の主な動向には、自動化および高スループットシステム、分子血液型分類法、抗体検出技術、患者血液管理プログラム、分析におけるaiの統合、遠隔医療統合などがあります。

予測される血液疾患の有病率の上昇が、当面の免疫血液学市場の成長を牽引します。赤血球、白血球、血小板、血漿などの血液成分に影響を及ぼす血液疾患では、安全で効果的な輸血のために免疫血液学の使用が必要となります。これにより、適合しない血液型やレシピエントの血液中の抗体の存在から生じる輸血反応を防ぐことができます。免疫血液学の技術は、免疫系に影響を与える疾患の診断と治療においても重要な役割を果たしており、血液学的システムにも影響を与える可能性があります。例えば、Cancer Research UKは、英国における血液疾患による新規白血病症例の増加が予想され、2023-2025年の約12,400症例から2038-2040年には約14,500症例に増加すると報告しています。このように、血液疾患の有病率の上昇は、免疫血液学市場の成長を支える重要な要因となっています。

免疫血液学市場の成長は、高齢化人口の増加によって牽引されると予測されます。高齢化とは、社会における高齢者の割合が高くなることを特徴とする人口動態を指します。免疫血液学は、この層の輸血ニーズを満たし、血液製剤の安全な使用を確保し、高齢者の医療介入を促進する上で重要な役割を果たしています。例えば、2024年1月、米国の非営利団体である人口問題研究所は、65歳以上の米国人の数が2022年の5,800万人から2050年には8,200万人になり、47％増加すると予測しています。さらに、この年齢層が総人口に占める割合は、同期間に17％から23％に増加すると予想されています。したがって、高齢化は免疫血液学市場の拡大を牽引する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界免疫血液学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の免疫血液学市場：成長率分析
• 世界の免疫血液学市場の実績：規模と成長, 2019-2024
• 世界の免疫血液学市場の予測：規模と成長, 2024-2029, 2034F
• 世界免疫血液学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の免疫血液学市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分析装置とシステム
• 試薬
• 世界の免疫血液学市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオチップ
• 赤血球磁化技術（Met）
• ジェルカード
• マイクロプレート
• ポリメラーゼ連鎖反応（PCR）
• 世界の免疫血液学市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液関連疾患
• HIV
• 肝炎
• 世界の免疫血液学市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 輸血前検査
• 免疫溶血の調査
• 周産期検査
• 血液型分類
• 白血球と血小板の血清学
• 世界の免疫血液学市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液銀行
• 診断および参照検査室
• 病院
• 学術研究機関
• 世界の免疫血液学市場、分析装置とシステムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液型分析装置
• クロスマッチングアナライザー
• ゲルカードシステム
• 世界の免疫血液学市場、試薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液型判定試薬
• 抗血清
• コントロール血清

第7章 地域別・国別分析

• 世界の免疫血液学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の免疫血液学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 免疫血液学市場：競合情勢
• 免疫血液学市場：企業プロファイル
  • Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Beckman Coulter Inc.
• Thermo Fisher Scientific Inc.
• Becton Dickinson and Company
• Merck Co. & KGaA
• Bio-Rad Laboratories
• Sysmex Corporation
• Danaher Corporation
• Biosystems S.A.
• Roche Holdings AG
• Mindray Medical International Limited
• F.Hoffmann La-Roche Ltd.
• Biotest AG
• Cardinal Health Inc.
• Quotient Limited
• DiaSorin S.p.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 免疫血液学市場2029：新たな機会を提供する国
• 免疫血液学市場2029：新たな機会を提供するセグメント
• 免疫血液学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Immunohematology is a subfield of laboratory medicine that focuses on the study of blood groups and the immune response of the body to foreign substances, particularly in the context of blood transfusions. Immunohematological techniques are employed to identify and address diagnostic issues in patients with hematological conditions, including auto-immune hemolytic anemia.

The main components of immunohematology include analyzers and systems, along with reagents. Analyzers and systems are automated instruments designed for blood typing and antibody screening. Various technologies are utilized in this field, such as biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR). These technologies are applied in the treatment of various diseases such as HIV and hepatitis. The diverse applications encompass pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, leucocyte and platelet serology. The end-users of immunohematology products include blood banks, diagnostic and reference laboratories, hospitals, as well as academic and research institutes.

The immunohematology market research report is one of a series of new reports from The Business Research Company that provides immunohematology optical components market statistics, including immunohematology optical components industry global market size, regional shares, competitors with a immunohematology optical components market share, detailed immunohematology optical components market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology optical components industry. This immunohematology optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market size has grown steadily in recent years. It will grow from$2.46 billion in 2024 to $2.57 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to advancements in blood transfusion science, the prevalence of blood disorders, the expansion of blood banks, government initiatives for blood safety, increased surgical procedures, and awareness of transfusion-related risks

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety. Major trends in the forecast period include automation and high-throughput systems, molecular blood typing methods, antibody detection techniques, patient blood management programs, integration of ai in analysis, telemedicine integration.

The anticipated rise in the prevalence of hematological disorders is set to drive the growth of the immunohematology market in the foreseeable future. Hematological disorders, affecting blood components such as red blood cells, white blood cells, platelets, and plasma, necessitate the use of immunohematology for safe and effective blood transfusions. This helps prevent transfusion reactions arising from incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques also play a crucial role in diagnosing and treating diseases impacting the immune system, with potential implications for the hematological system. For instance, Cancer Research UK reported an expected increase in new leukemia cases due to hematological disorders in the UK, rising from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the escalating prevalence of hematological disorders is a key driver behind the growth of the immunohematology market.

The growth of the immunohematology market is anticipated to be driven by the increasing aging population. An aging population refers to a demographic trend marked by a higher proportion of elderly individuals within a society. Immunohematology plays a crucial role in meeting the transfusion needs of this demographic, ensuring the safe use of blood products, and facilitating medical interventions for older adults. For instance, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, this age group's share of the total population is expected to grow from 17% to 23% during the same period. Therefore, the aging population is a significant factor driving the expansion of the immunohematology market.

Leading companies in the immunohematology market are focused on creating innovative diagnostic solutions, such as soluble recombinant proteins that can mitigate the interference caused by the cancer therapy daratumumab. Soluble recombinant proteins are produced using recombinant DNA technology, maintaining their proper structure and functionality in a soluble form within a host cell or solution, making them suitable for research and therapeutic applications. For example, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, introduced the Grifols sCD38 solution. This product is the first-ever soluble recombinant protein developed specifically to address the interference that daratumumab causes in essential blood transfusion compatibility testing. Targeted at patients with multiple myeloma, this groundbreaking solution prevents daratumumab from binding to CD38 proteins on red blood cells, ensuring accurate pre-transfusion test results. By streamlining the processes of screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and reduces delays in administering lifesaving transfusions.

Major companies operating in the immunohematology market are innovating by introducing new products such as self-sampling blood collection products to enhance their market profitability. Self-sampling blood collection involves individuals collecting their own blood samples for diagnostic purposes without the need for healthcare professionals. For example, in February 2023, Capitainer launched CapitainerB 50, a self-sampling blood collection device that protects samples from contamination. The microsampling technology employed ensures precise quantitative sampling comparable to conventional pipetting.

In March 2023, Werfen, S.A., a diagnostic care company based in Spain, completed the acquisition of Immucor Inc. for approximately $2 billion. This strategic move aimed to expand Werfen's capabilities in specialized diagnostic testing, particularly within diagnostic solutions. Immucor Inc., a transfusion diagnostics company based in Spain, focuses on providing safe, accessible, and affordable blood tests.

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohematology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohematology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohematology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunohematology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Analyzers And Systems; Reagents
• 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (Met); Gel Cards; Microplates; Polymerase Chain Reaction (PCR)
• 3) By Disease: Blood-Related Diseases; HIV; Hepatitis
• 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
• 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
• Subsegments:
• 1) By Analyzers And Systems: Blood Typing Analyzers; Cross-Matching Analyzers; Gel Card Systems
• 2) By Reagents: Blood Grouping Reagents; Antisera; Control Serum
• Companies Mentioned: Ortho Clinical Diagnostics Inc.; Immunocor Inc.; Abbott Laboratories; Siemens Healthineers AG; Grifols S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunohematology Market Characteristics

3. Immunohematology Market Trends And Strategies

4. Immunohematology Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Immunohematology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Immunohematology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Immunohematology Market Growth Rate Analysis
• 5.4. Global Immunohematology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Immunohematology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Immunohematology Total Addressable Market (TAM)

6. Immunohematology Market Segmentation

• 6.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analyzers And Systems
• Reagents
• 6.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biochips
• Erythrocyte-Magnetized Technology (Met)
• Gel Cards
• Microplates
• Polymerase Chain Reaction (PCR)
• 6.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood-Related Diseases
• HIV
• Hepatitis
• 6.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pretransfusion Testing
• Investigation Of Immune Hemolysis
• Perinatal Testing
• Blood Group Phenotyping
• Leucocyte And Platelet Serology
• 6.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Banks
• Diagnostic And Reference Laboratories
• Hospitals
• Academic And Research Institutes
• 6.6. Global Immunohematology Market, Sub-Segmentation Of Analyzers And Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Typing Analyzers
• Cross-Matching Analyzers
• Gel Card Systems
• 6.7. Global Immunohematology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Grouping Reagents
• Antisera
• Control Serum

7. Immunohematology Market Regional And Country Analysis

• 7.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunohematology Market

• 8.1. Asia-Pacific Immunohematology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunohematology Market

• 9.1. China Immunohematology Market Overview
• 9.2. China Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunohematology Market

• 10.1. India Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunohematology Market

• 11.1. Japan Immunohematology Market Overview
• 11.2. Japan Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunohematology Market

• 12.1. Australia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunohematology Market

• 13.1. Indonesia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunohematology Market

• 14.1. South Korea Immunohematology Market Overview
• 14.2. South Korea Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunohematology Market

• 15.1. Western Europe Immunohematology Market Overview
• 15.2. Western Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunohematology Market

• 16.1. UK Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunohematology Market

• 17.1. Germany Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunohematology Market

• 18.1. France Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunohematology Market

• 19.1. Italy Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunohematology Market

• 20.1. Spain Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunohematology Market

• 21.1. Eastern Europe Immunohematology Market Overview
• 21.2. Eastern Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunohematology Market

• 22.1. Russia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunohematology Market

• 23.1. North America Immunohematology Market Overview
• 23.2. North America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunohematology Market

• 24.1. USA Immunohematology Market Overview
• 24.2. USA Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunohematology Market

• 25.1. Canada Immunohematology Market Overview
• 25.2. Canada Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunohematology Market

• 26.1. South America Immunohematology Market Overview
• 26.2. South America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunohematology Market

• 27.1. Brazil Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunohematology Market

• 28.1. Middle East Immunohematology Market Overview
• 28.2. Middle East Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunohematology Market

• 29.1. Africa Immunohematology Market Overview
• 29.2. Africa Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunohematology Market Competitive Landscape And Company Profiles

• 30.1. Immunohematology Market Competitive Landscape
• 30.2. Immunohematology Market Company Profiles
  • 30.2.1. Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Immunohematology Market Other Major And Innovative Companies

• 31.1. Beckman Coulter Inc.
• 31.2. Thermo Fisher Scientific Inc.
• 31.3. Becton Dickinson and Company
• 31.4. Merck Co. & KGaA
• 31.5. Bio-Rad Laboratories
• 31.6. Sysmex Corporation
• 31.7. Danaher Corporation
• 31.8. Biosystems S.A.
• 31.9. Roche Holdings AG
• 31.10. Mindray Medical International Limited
• 31.11. F.Hoffmann La-Roche Ltd.
• 31.12. Biotest AG
• 31.13. Cardinal Health Inc.
• 31.14. Quotient Limited
• 31.15. DiaSorin S.p.A.

32. Global Immunohematology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunohematology Market

34. Recent Developments In The Immunohematology Market

35. Immunohematology Market High Potential Countries, Segments and Strategies

• 35.1 Immunohematology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Immunohematology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Immunohematology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer